Medy-Tox Inc (086900)

Currency in KRW
143,400
+600(+0.42%)
Closed·
086900 Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 3 days
Fair Value
Day's Range
141,900144,500
52 wk Range
112,100218,000
Key Statistics
Bid/Ask
143,300.00 / 143,400.00
Prev. Close
143,400
Open
144,500
Day's Range
141,900-144,500
52 wk Range
112,100-218,000
Volume
29.01K
Average Volume (3m)
53.83K
1-Year Change
-13.39%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
086900 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
212,833
Upside
+48.42%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Medy-Tox Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Medy-Tox Inc Company Profile

Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials. In addition, it provides various medical devices, such as ComfortDual for tissue coagulation by using high-frequency current; Neurajet Plus to assist injecting other pharmaceuticals; and Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method. It also exports its products to approximately 60 countries, including Japan, Brazil, and internationally. Medy-Tox Inc. was founded in 2000 and is headquartered in Cheongju, South Korea.

Employees
724

Compare 086900 to Peers and Sector

Metrics to compare
086900
Peers
Sector
Relationship
P/E Ratio
47.4x1.1x−0.5x
PEG Ratio
0.060.040.00
Price/Book
2.2x1.9x2.6x
Price / LTM Sales
4.2x7.9x3.3x
Upside (Analyst Target)
45.4%44.7%43.5%
Fair Value Upside
Unlock16.8%6.3%Unlock

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 212,833
(+48.42% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2,677.00%
Dividend Yield
0.77%
Industry Median 0.93%
Annualised payout
1,100.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 12, 2025
EPS / Forecast
427.00 / 2,789.00
Revenue / Forecast
64.00B / 60.15B
EPS Revisions
Last 90 days

086900 Income Statement

People Also Watch

101,400
000270
-1.36%
961,000
012450
+2.45%
32,650
004020
+0.46%
45,950
000990
+0.99%
25,750
028050
+1.58%

FAQ

What Stock Exchange Does Medy-Tox Trade On?

Medy-Tox is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Medy-Tox?

The stock symbol for Medy-Tox is "086900."

What Is the Medy-Tox Market Cap?

As of today, Medy-Tox market cap is 1.01T.

What Is Medy-Tox's Earnings Per Share (TTM)?

The Medy-Tox EPS (TTM) is 2,677.00.

When Is the Next Medy-Tox Earnings Date?

Medy-Tox will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is 086900 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medy-Tox Stock Split?

Medy-Tox has split 7 times.

How Many Employees Does Medy-Tox Have?

Medy-Tox has 724 employees.

What is the current trading status of Medy-Tox (086900)?

As of 05 Aug 2025, Medy-Tox (086900) is trading at a price of 143,400.00, with a previous close of 143,400.00. The stock has fluctuated within a day range of 141,900.00 to 144,500.00, while its 52-week range spans from 112,100.00 to 218,000.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.